JNJ news and market impact
Real-time Johnson & Johnson news affecting stock and options prices
Latest JNJ news
E.l.f. Beauty CFO Mandy Fields on consumers, pricing and building a foundation in cosmetics.
E.l.f. Beauty CFO Mandy Fields on consumers, pricing and building a foundation in cosmetics
Here's our monthly update on our 32 stocks, including 2 more names to buy.
Here's our monthly update on our 32 stocks, including 2 more names to buy
Accion Opportunity Fund Honored as a Finalist in Campaign (Non-Profit), Humanitarian Action & Services for The 6th Annual Anthem Awards.
Accion Opportunity Fund Honored as a Finalist in Campaign (Non-Profit), Humanitarian Action & Services for The 6th Annual Anthem Awards
$FDX 8-K · FEDEX CORP · Item 5.07 Submission of Matters to a Vote of Security Holders + Item 8.01 Other Events.
$FDX 8-K · FEDEX CORP · Item 5.07 Submission of Matters to a Vote of Security Holders + Item 8.01 Other Events
We're upgrading our rating on Wells Fargo as the stock's pullback offers a nice entry point.
We're upgrading our rating on Wells Fargo as the stock's pullback offers a nice entry point
Meta shares rise for a second straight day as new AI model family impresses.
Meta shares rise for a second straight day as new AI model family impresses
We're upgrading our Goldman Sachs rating after a strong quarter bodes well for the future.
We're upgrading our Goldman Sachs rating after a strong quarter bodes well for the future
Stocks making the biggest moves midday: Apple, Meta Platforms, Bumble, Fermi, Goldman Sachs & more.
Stocks making the biggest moves midday: Apple, Meta Platforms, Bumble, Fermi, Goldman Sachs & more
Johnson & Johnson Q3 Preview: Analyst Projects In-Line Sales, Earnings Miss - Benzinga.
Johnson & Johnson Q3 Preview: Analyst Projects In-Line Sales, Earnings Miss - Benzinga
Phanes Therapeutics to participate in Longwood Healthcare Leaders Boston CEO, November 2-3, 2026.
Phanes Therapeutics to participate in Longwood Healthcare Leaders Boston CEO, November 2-3, 2026
How news affects JNJ
Johnson & Johnson (JNJ) is sensitive to: drug approvals, litigation, earnings, FDA regulation.Diversified pharma and medical devices — post consumer health spinoff.
Related tickers
Get JNJ alerts before the market moves
AI-powered news filtering. Only what matters to your positions.
Start free trialFrequently asked questions
What is moving JNJ today?
E.l.f. Beauty CFO Mandy Fields on consumers, pricing and building a foundation in cosmetics.
How do I get JNJ news alerts?
Sign up for Tradar and add JNJ to your watchlist. You'll get push notifications for high-impact news within seconds.